Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07387718
Eligibility Criteria:
Inclusion (Eligibility) Criteria for Caregivers or Parents:
* The participant must be at least 18 years old.
* The participant must be willing and able to participate.
* The participant can read English or Spanish and is able to fill out survey instruments by themselves or with assistance.
* The participant cares for a child with asthma.
Exclusion (Eligibility) Criteria for Caregivers or Parents:
* The participant is younger than 18 years old.
* The participant is unwilling to participate in the study.
* The participant is unable to complete survey instruments.
* The participant does not care for a child with asthma.
Inclusion (Eligibility) Criteria for Children:
* The participant must be at least 3 years old - 17 years old with asthma.
* The participant must assent to participation.
* The participant's guardian must have consented.
Exclusion (Eligibility) Criteria for Children:
* The participant is younger than 3 years old.
* The participant does not have asthma.
* The participant is unwilling to participate in the study.
* The participant's guardian did not consent.
Inclusion (Eligibility) Criteria for Healthcare Providers:
* The participant must be at least 18 years old.
* The participant must be willing and able to participate.
* The participant can read English and is able to fill out survey instruments by themselves.
* The participant must view a robotic education session.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Years
Study:
NCT07387718
Study Brief:
Protocol Section:
NCT07387718